Plasma amyloid-β as a biomarker in alzheimer's disease: The AIBL study of aging
Version 2 2024-06-04, 15:54Version 2 2024-06-04, 15:54
Version 1 2021-09-28, 08:07Version 1 2021-09-28, 08:07
journal contribution
posted on 2024-06-04, 15:54authored byJK Lui, SM Laws, QX Li, VL Villemagne, D Ames, B Brown, AI Bush, K De Ruyck, J Dromey, KA Ellis, NG Faux, J Foster, C Fowler, Veer GuptaVeer Gupta, P Hudson, K Laughton, CL Masters, K Pertile, A Rembach, M Rimajova, M Rodrigues, CC Rowe, R Rumble, C Szoeke, K Taddei, T Taddei, B Trounson, V Ward, RN Martins
Plasma amyloid-β as a biomarker in alzheimer's disease: The AIBL study of aging